Mar 8, 2024 · The detection of lesions that are less than 5 mm in size by current PSMA positron emission tomography (PET) imaging agents (including PYLARIFY® ...
People also ask
What are the results of Clarity Cobra?
Feb 15, 2024 · Initial data from Clarity's diagnostic Phase 1/2 trial, COBRA, confirms 64Cu-SAR-bisPSMA is safe and highly effective in detecting prostate ...
Missing: prnewswire. 302080984.
3 days ago · The COBRA trial involves 50 patients with BCR, aiming to assess the safety, tolerability, and detection rate of SAR-bisPSMA imaging. Initial ...
Missing: prnewswire. releases/ 302080984.
Dec 22, 2023 · Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range. Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical ...
Missing: 302080984. | Show results with:302080984.
Mar 15, 2024 · Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range. Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical ...
Missing: 302080984. | Show results with:302080984.
Mar 8, 2024 · Clarity Pharmaceuticals Ltd. Announces Additional COBRA Results: SAR-bisPSMA Detects Lesions in the 2-Millimetre Range. March 08, 2024 at 09:02 ...
Missing: prnewswire. 302080984. html
May 24, 2023 · Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range. Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical ...
Missing: 302080984. | Show results with:302080984.
Apr 30, 2024 · The patient had no detectable lesions using positron emission tomography (PET) imaging with 64Cu-SAR-bisPSMA following the treatment. The first ...
Feb 15, 2024 · The trial demonstrates a clinical advantage of same-day and next-day imaging in detecting additional lesions as well as for potentially ...
Missing: prnewswire. millimetre- 302080984. html
In order to show you the most relevant results, we have omitted some entries very similar to the 9 already displayed.
If you like, you can repeat the search with the omitted results included. |